A phase I study to evaluate the safety of ascending doses of FPA144 in combination with chemotherapy
Phase of Trial: Phase I
Latest Information Update: 15 Aug 2017
At a glance
- Drugs FPA 144 (Primary)
- Indications Gastric cancer
- Focus Adverse reactions
- 15 Aug 2017 New trial record
- 08 Aug 2017 According to a Five Prime Therapeutics media release, This safety trial will support the start of the global Phase 3 clinical trial.
- 08 Aug 2017 According to a Five Prime Therapeutics media release, the company plans to begin dosing in this trial by the end of 2017.